Evidence map›Paper›PMID 35039642›Full record

ArticleScientific reports2022

Author Correction: BDNF Val66Met gene polymorphism modulates brain activity following rTMS-induced memory impairment.

Kilian Abellaneda-Pérez, Pablo Martin-Trias, Catherine Cassé-Perrot, Lídia Vaqué-Alcázar, Laura Lanteaume, Elisabeth Solana, Claudio Babiloni, Roberta Lizio, Carme Junqué, Núria Bargalló and 13 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 5 countries.

Kilian Abellaneda-Pérez *Medical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, C/ Casanova, 143, 08036, Barcelona, Spain.
Pablo Martin-Trias *Medical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, C/ Casanova, 143, 08036, Barcelona, Spain.
Catherine Cassé-PerrotCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Lídia Vaqué-AlcázarMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, C/ Casanova, 143, 08036, Barcelona, Spain.
Laura LanteaumeCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Elisabeth SolanaInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Claudio BabiloniDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.
Roberta LizioIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) SDN, Naples, Italy.
Carme JunquéMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, C/ Casanova, 143, 08036, Barcelona, Spain.
Núria BargallóNeuroradiology Section, Radiology Department, Diagnostic Image Center, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Paolo Maria RossiniDepartment of Neuroscience and Neurorehabilitation, IRCCS S. Raffaele, Rome, Italy.
Joëlle MicallefCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Romain TruilletCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Estelle CharlesCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Elisabeth JouveCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Régis BordetInserm, CHU Lille, U1171, Degenerative and Vascular Cognitive Disorders, University of Lille, Lille, France.
Joan SantamariaInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Simone RossiDipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Brain Investigation & Neuromodulation Laboratory (Si‑BIN Lab), University of Siena, Siena, Italy.
Alvaro Pascual-LeoneHinda and Arthur Marcus Institute for Aging Research and Deanna and Sidney Wolk Center for Memory Health, Hebrew SeniorLife, Boston, MA, USA.
Olivier BlinCIC CPCET Service de Pharmacologie Clinique et Pharmacovigilance, CHU Timone, AP-HM, Marseille, France.
Jill RichardsonNeurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, UK.
Jorge JovicichCenter for Mind/Brain Sciences (CIMEC), University of Trento, Trento, Italy.
David Bartrés-FazMedical Psychology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, C/ Casanova, 143, 08036, Barcelona, Spain. dbartres@ub.edu.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESInserm · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversitat de Barcelona · ESGlaxoSmithKline (United Kingdom) · GBHarvard University · USInstitut Guttmann · ESUniversity of Siena · ITUniversity of Trento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35039642
PMCPMC8763898
OpenAlexW4206020595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.